Markets.com Logo

IPTK

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0$
  • Previous Close
    0$
  • 52 Week Change
    0.00$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.0001$ - 0.0018$
  • Dividend Per Share
    --
  • Market cap
    28 651$
  • EPS
    -0.0009
  • Beta
    -521.577
  • Volume
    --

About

IPTK.US represents ImmunoPrecise Antibodies Ltd., a biopharmaceutical company. It focuses on developing and manufacturing human antibodies for various therapeutic and diagnostic applications. The company leverages its proprietary technology platforms to discover, engineer, and optimize antibodies for its partners and its own internal pipeline.

AMD's Share Price Surges to Record Highs Driven by Server CPU Momentum

Noah Lee|--

Gold Volatility: Is a Structural Shift Underway? An In-depth Analysis

Noah Lee|--

S&P 500's Record Rally Continues: Nomura Strategist Flags Two Key Exit Signals

Liam James|--
Crypto Market Analysis: Why Does South Korea Now Account for 30% of Global Crypto Trading Volume?

Crypto Market Analysis: Why Does South Korea Now Account for 30% of Global Crypto Trading Volume?

Ghko B|--
Forex market analysis: NZD/USD approaches 0.5900, what could influence its next moves?

Forex market analysis: NZD/USD approaches 0.5900, what could influence its next moves?

Frances Wang|--
Stock Market Analysis: How Much Will S&P 500 Strength Influence UAE Stock Recovery in 2026?

Stock Market Analysis: How Much Will S&P 500 Strength Influence UAE Stock Recovery in 2026?

Ghko B|--

Trump's Papal Challenge: A Clash Over Moral Authority and Political Influence

Noah Lee|--

Factors

Clinical Trial Results: Positive trial outcomes for IPTK's drug candidates typically drive the stock price up, while negative results can cause it to plummet. Regulatory Approvals: FDA approval of a drug significantly increases its commercial potential, leading to a stock price surge. Denials or delays in approval negatively impact the stock. Market Competition: The presence of competing drugs or therapies can influence the demand and pricing of IPTK's products, thus affecting the stock price. Partnerships & Collaborations: Strategic alliances with larger pharmaceutical companies can provide financial support and market access, boosting investor confidence. Financial Performance: IPTK's revenue, profitability, and cash flow directly impact its valuation and stock price. Strong financial performance attracts investors. Overall Market Conditions: Broad market trends, such as economic growth or recession, and investor sentiment, can influence the demand for IPTK's stock. Intellectual Property: The strength and validity of IPTK's patents protect its market exclusivity and contribute to its value, impacting the stock price. Management Team: The experience and reputation of IPTK's leadership team can affect investor confidence and the company's ability to execute its strategy. News and Events: Company-specific news, such as earnings releases, product launches, and industry conferences, can create short-term price fluctuations.

People Also Watch

Latest news

SpaceX Accelerates Employee Stock Vesting as IPO Approaches with Record Valuation Target

Sophia Claire|--

Israel-Lebanon Peace Talks: Historic Step Toward De-escalation, Yet Shadowed by Hezbollah's Absence

Sophia Claire|--

ECB's Interest Rate Path: Navigating Uncertainty Amidst Volatile Price Dynamics

Emma Rose|--

Latest Education Articles

How to Trade Natural Gas in 2026

How to Trade Natural Gas in 2026

Julian Parker|--
Gold or Silver CFDs? Key Differences Every CFD Trader Should Know

Gold or Silver CFDs? Key Differences Every CFD Trader Should Know

Julian Parker|--
Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Bonds vs. Stocks in CFD Trading: What Traders Need to Understand

Julian Parker|--
Recommended Topics